Cargando…

Clinical characteristics and long-term prognosis of ischemic and non-ischemic cardiomyopathy

OBJECTIVES: The different etiology of HF has different prognostic risk factors. Prognosis assessment of ICM and NICM has important clinical value. This study is aimed to explore the predicting factors for ICM and NICM. METHODS: 1082 HFrEF patients were retrospectively enrolled from Jan. 01, 2016 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhi-hua, Meng, Fan-qi, Hou, Xiao-feng, Qian, Zhi-yong, Wang, Yao, Qiu, Yuan-hao, Jiang, Zhe-yu, Du, An-jie, Qin, Chao-tong, Zou, Jian-gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296233/ https://www.ncbi.nlm.nih.gov/pubmed/32534695 http://dx.doi.org/10.1016/j.ihj.2020.04.004

Ejemplares similares

Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy
por: Gao, Wei, et al.
Publicado: (2023)

Prognosis of Coronary Atherosclerotic Burden in Non-Ischemic Dilated Cardiomyopathies
por: Canu, Marjorie, et al.
Publicado: (2021)

Ischemic stroke patients with prestroke dependency: Characteristics and long‐term prognosis
por: Sennfält, Stefan, et al.
Publicado: (2020)

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
por: Yokoshiki, Hisashi, et al.
Publicado: (2017)

Ferroptosis and Autophagy-Related Genes in the Pathogenesis of Ischemic Cardiomyopathy
por: Zheng, Yue, et al.
Publicado: (2022)

Sex Differences in Prognosis of Heart Failure Due to Ischemic and Nonischemic Cardiomyopathy
por: Mansur, Antonio de Padua, et al.
Publicado: (2023)

Identification of a Common Different Gene Expression Signature in Ischemic Cardiomyopathy
por: Li, Yana, et al.
Publicado: (2018)

Multimodality Imaging in Ischemic Cardiomyopathy
por: Prior, John O., et al.
Publicado: (2014)

Alteration of Cholinergic Anti‐Inflammatory Pathway in Rat With Ischemic Cardiomyopathy–Modified Electrophysiological Function of Heart
por: Wu, Shu‐Jie, et al.
Publicado: (2017)

A TRPV1 common missense variant affected the prognosis of ischemic cardiomyopathy
por: Li, Shiyang, et al.
Publicado: (2022)

Cardiac Proteome Profiling in Ischemic and Dilated Cardiomyopathy Mouse Models
por: Lu, Danbo, et al.
Publicado: (2019)

Asymmetrical cortical vessel sign predicts prognosis after acute ischemic stroke
por: Liu, Yong‐Lin, et al.
Publicado: (2020)

Ischemic Cardiomyopathy versus Non-Ischemic Dilated Cardiomyopathy in Patients with Reduced Ejection Fraction— Clinical Characteristics and Prognosis Depending on Heart Failure Etiology (Data from European Society of Cardiology Heart Failure Registries)
por: Tymińska, Agata, et al.
Publicado: (2022)

Risk factors and a Bayesian network model to predict ischemic stroke in patients with dilated cardiomyopathy
por: Fan, Ze-Xin, et al.
Publicado: (2022)

Statistical suggestions for long-term outcomes for non-ischemic dilated cardiomyopathy
por: Agstam, Sourabh, et al.
Publicado: (2021)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Long-Term Prognosis of Ischemic Stroke in Young Adults
por: Varona, Jose F.
Publicado: (2010)

Correlation of the systemic immune-inflammation index with short- and long-term prognosis after acute ischemic stroke
por: Wang, Nan, et al.
Publicado: (2022)

Social Inequalities in Non-ischemic Cardiomyopathies
por: Amiya, Eisuke
Publicado: (2022)

Epicardial–Endocardial Reentry in Ischemic Cardiomyopathy
por: Kotake, Yasuhito, et al.
Publicado: (2021)

Multimodality Imaging in Ischemic Chronic Cardiomyopathy
por: Muscogiuri, Giuseppe, et al.
Publicado: (2022)

Accurate Classification of Non-ischemic Cardiomyopathy
por: Wang, Yifan, et al.
Publicado: (2023)

Remote ischemic conditioning for the treatment of ischemic moyamoya disease
por: Ding, Jia‐yue, et al.
Publicado: (2019)

Influence and risk factors of postoperative infection after surgery for ischemic cardiomyopathy
por: Wen, Bing, et al.
Publicado: (2023)

Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy
por: Díez-López, Carles, et al.
Publicado: (2022)

Serum lipids profiling perturbances in patients with ischemic heart disease and ischemic cardiomyopathy
por: Yang, Lin, et al.
Publicado: (2020)

Ceruloplasmin and the Extent of Heart Failure in Ischemic and Nonischemic Cardiomyopathy Patients
por: Xu, Yifei, et al.
Publicado: (2013)

Bioinformatics and Experimental Analyses Reveal NFIC as an Upstream Transcriptional Regulator for Ischemic Cardiomyopathy
por: Ye, Yang, et al.
Publicado: (2022)

The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy
por: Wang, Xianyun, et al.
Publicado: (2015)

Long-Term Prognostic Value of Restitution Slope in Patients with Ischemic and Dilated Cardiomyopathies
por: Dorenkamp, Marc, et al.
Publicado: (2013)

Statistical suggestions for long-term outcomes of non-ischemic dilated cardiomyopathy patients
por: Bursa, Nurbanu
Publicado: (2021)

Long-Term Results of Hybrid Left Ventricular Reconstruction in the Treatment of Ischemic Cardiomyopathy
por: Naar, Jan, et al.
Publicado: (2021)

Sex-Specific Predictors of Long-Term Mortality in Elderly Patients with Ischemic Cardiomyopathy
por: Yoon, Hyun Ju, et al.
Publicado: (2023)

Correlations between NLR, NHR, and clinicopathological characteristics, and prognosis of acute ischemic stroke
por: Zhu, Feng, et al.
Publicado: (2023)

Diagnostic accuracy of different CMR techniques in the evaluation of ischemic cardiomyopathy
por: Won, Eugene, et al.
Publicado: (2013)

Short-term vs. long-term heart rate variability in ischemic cardiomyopathy risk stratification
por: Voss, Andreas, et al.
Publicado: (2013)

Parameters of Right Ventricle as etiological distinction between ischemic and non-ischemic dilated cardiomyopathy
por: Gomes, Hélder Andrade, et al.
Publicado: (2015)

Searching for Intrinsic Causality between Colonic Dysbiosis and Non-Ischemic Cardiomyopathy: A Mendelian Randomization-Based Analysis
por: Qi, Bin, et al.
Publicado: (2023)

Cardiovascular dynamics in ischemic cardiomyopathy during exercise
por: van der Wall, E. E., et al.
Publicado: (2009)

Nanomedicine for ischemic cardiomyopathy: progress, opportunities, and challenges
por: Mahmoudi, Morteza
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5adbf1sckapendaq9l585ah2h5